Latest filing published 08 Mar 2024 for Xenon Pharmaceuticals Inc., €9,066.
Filing timeline
BuySaleInsider track record
Sherrington Robin: trading record in brief
Sherrington Robin is a declared insider of Xenon Pharmaceuticals Inc. (chief executive), with filings sourced from SEC (Form 4). Over a trading history stretching from 18 August 2015 to 7 March 2024, the count stands at 42 filings.
Every open-market trade on record is a sale: 11 sales worth €3.5M. The rest of the record consists of 14 share grants and 16 option exercises. So far in 2024, the count stands at no purchases and 2 sales.
The newest entry dates from 8 March 2024: a share grant of €9,066, in Xenon Pharmaceuticals Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Sherrington Robin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 215 shares@ US$45.960.2% of flowCommon SharesSEC:0000950170-24-028795:1
- 7,407 shares@ US$9.851.5% of flowCommon SharesSEC:0000950170-24-028795:2
- 1,289 shares@ US$45.961.2% of flowCommon SharesSEC:0000950170-24-028795:3
- 1,019 shares@ US$46.150.9% of flowCommon SharesSEC:0000950170-24-028795:4
- 6,118 shares@ US$46.305.7% of flowCommon SharesSEC:0000950170-24-028795:5
- 1,234 shares@ US$9.8519.3% of flowCommon SharesSEC:0000950170-24-028795:0
- 8,398 shares0Common SharesSEC:0000950170-24-000304:0
- 5,000 shares@ US$4.750.5% of flowCommon SharesSEC:0001209191-22-048508:1
- 1,572 shares@ US$37.861.3% of flowCommon SharesSEC:0001209191-22-048508:2
- 21,352 shares@ US$38.5718.1% of flowCommon SharesSEC:0001209191-22-048508:3
- 50,000 shares@ US$4.755.3% of flowCommon SharesSEC:0001209191-22-048508:4
- 6,121 shares@ US$38.815.3% of flowCommon SharesSEC:0001209191-22-048508:5
- 35,103 shares@ US$38.0329.5% of flowCommon SharesSEC:0001209191-22-048508:6
- 8,776 shares@ US$38.807.5% of flowCommon SharesSEC:0001209191-22-048508:7
- 17,488 shares@ US$2.6780.7% of flowCommon SharesSEC:0001209191-22-048508:0
- 696 shares@ US$31.420.4% of flowCommon SharesSEC:0001209191-22-017318:1
- 6,172 shares@ US$3.670.5% of flowCommon SharesSEC:0001209191-22-017318:2
- 6,710 shares@ US$30.564.1% of flowCommon SharesSEC:0001209191-22-017318:3
- 5,000 shares@ US$30.153.0% of flowCommon SharesSEC:0001209191-22-017318:4
- 5,000 shares@ US$31.053.1% of flowCommon SharesSEC:0001209191-22-017318:5
- 5,000 shares@ US$30.233.0% of flowCommon SharesSEC:0001209191-22-017318:6
- 1,234 shares@ US$3.679.7% of flowCommon SharesSEC:0001209191-22-017318:0
- 2,024 shares@ US$18.917.7% of flowCommon SharesSEC:0001209191-21-036802:1
- 13,374 shares@ US$3.8510.3% of flowCommon SharesSEC:0001209191-21-036802:2
- 2,192 shares@ US$18.918.3% of flowCommon SharesSEC:0001209191-21-036802:3
25 of 38 declarations
